Bioengineered CRISPR/Cas9-based transcriptional activators for controlling cell-fate decisions
10th November 2020
Bioengineered CRISPR/Cas9-based transcriptional activators for controlling cell-fate decisions
The following study was conducted by Scientists from University Program in Genetics and Genomics, Duke…
